GOWTHAMI AREPALLY, MD
Osteopathic Medicine in Durham, NC

License number
North Carolina 2001-01519
Category
Osteopathic Medicine
Type
Hematology
Address
Address
Duke University Medical Ctr, Durham, NC 27710
Phone
(919) 620-4467

Personal information

See more information about GOWTHAMI AREPALLY at radaris.com
Name
Address
Phone
Gowthami Arepally, age 60
43 Beverly Dr, Durham, NC 27707
(919) 403-7440
Gowthami Arepally
Durham, NC
(919) 403-7440
Gowthami O Arepally, age 60
1515 Hermitage Ct, Durham, NC 27707
(919) 403-7440
Gowthami O Arepally, age 60
43 Beverly Dr, Durham, NC 27707
(919) 403-7440

Organization information

See more information about GOWTHAMI AREPALLY at bizstanding.com

Gowthami Arepally MD

1000 Trent Dr, Durham, NC 27710

Industry:
Internist
Phone:
(800) 266-3853 (Phone)
Gowthami Morey Arepally


Gowthami Arepally MD

201 Trent Dr Mc 3422, Durham, NC 27707

Categories:
Hematology Physicians & Surgeons
Phone:
(919) 684-5350 (Phone)

Professional information

Gowthami Arepally Photo 1

Compositions And Methods Useful For The Diagnosis And Treatment Of Heparin Induced Thrombocytopenia/Thrombosis

US Patent:
7728115, Jun 1, 2010
Filed:
Aug 2, 2005
Appl. No.:
11/195095
Inventors:
Gowthami M. Arepally - Durham NC, US
Walter Kisiel - Albuquerque NM, US
Keiko Kamei - Kumamoto, JP
Shintaro Kamei - Kumamoto, JP
Assignee:
STC. UNM - Albuquerque NM
International Classification:
C07K 16/18, C12P 21/08, G01N 33/564, G01N 33/577, C12N 5/20
US Classification:
5303887, 435 724, 435 691, 435 7021, 435452, 435332, 435337, 435975, 436506, 436512, 436548, 5303873, 53038825, 530866
Abstract:
The invention includes compositions, kits and methods comprising a monoclonal antibody which shares key functional properties with the polyclonal antibodies which participate in the pathogenesis of heparin induced thrombocytopenia/thrombosis (HIT/HITT) in a mammal. The monoclonal antibody of the invention preferentially binds with a PF4/heparin complex relative to the binding of the antibody with PF4 or heparin alone. The monoclonal antibody of the invention also binds specifically with PF4 in a complex with other glycosaminoglycans besides heparin, and also activates platelets. The monoclonal antibody of the invention is useful in methods for diagnosing and treating HIT/HITT in a mammal. A humanized version of the monoclonal antibody of the invention is also included, along with a process for humanizing the monoclonal antibody of the invention.


Gowthami Arepally Photo 2

Gowthami Arepally, Durham NC

Specialties:
Pediatrics, Pediatric Hematology-Oncology, Internal Medicine, Hematology, Hematology & Oncology, Medical Oncology, Hematology
Work:
Durham Va Medical Center
508 Fulton St, Durham, NC 27705 Private Diagnostic Clinic
1000 Trent Dr, Durham, NC 27710
Education:
Vanderbilt University (1989)


Gowthami Arepally Photo 3

Dr. Gowthami Arepally, Durham NC - MD (Doctor of Medicine)

Specialties:
Hematology, Medical Oncology, Oncology
Address:
Durham Office
1 Duke Medical Ctr, Durham 27710
(919) 684-8111 (Phone), (919) 681-8679 (Fax)
Duke Medical Center Hematology
201 Trent Dr SUITE MC3422, Durham 27710
(919) 684-5350 (Phone)
Certifications:
Hematology, 1996, Internal Medicine, 1992, Medical Oncology, 1997
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Vanderbilt University
Graduated: 1989


Gowthami M Arepally Photo 4

Gowthami M Arepally, Durham NC

Specialties:
Hematologist
Address:
Duke University Medical Ctr, Durham, NC 27710
Education:
Doctor of Medicine
Board certifications:
American Board of Internal Medicine Sub-certificate in Hematology (Internal Medicine)


Gowthami Arepally Photo 5

Platelet Surface Pf4 Antigenic Complexes As A Diagnostic Indicator In Heparin-Induced Thrombocytopenia

US Patent:
2007019, Aug 16, 2007
Filed:
Dec 20, 2006
Appl. No.:
11/613787
Inventors:
Mortimer Poncz - Philadelpia PA, US
Douglas Cines - Wynnewood PA, US
Gowthami Arepally - Durham NC, US
Lubica Rauova - Philadelpia PA, US
International Classification:
G01N 33/567
US Classification:
435007210
Abstract:
A method for diagnosing a predisposition for developing HIT is provided.